Kinnate Biopharma KNTE
$ 2.65
0.0%
Annual report 2023
added 03-28-2024
Country |
USA |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Nima Farzan |
Employees in the company |
- |
Shares |
46.6 M |
Market Cap[1] |
$ 123 M |
EBITDA (LTM) |
$ -120 M |
P/E (LTM) |
-0.44 |
P/S (LTM) |
- |
EPS (LTM) |
-2.76 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.